Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APARR
NCT06646497Phase 2Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jan 2025
- Primary completion
- Jan 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide in aplastic anemia, sponsored by Assistance publique - Hôpitaux de Paris. Started Jan 2025; status: recruiting.
02
Drugs
cyclophosphamide
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT06646497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06646497.